The money keeps flowing

The company predicts a further US$2.5bn will be invested in new IT healthcare start-ups over the next two years – by which time half, again, will fail – before yet more purging will commence.

“Rather than discard the investment that has been made in getting sputtering start-ups off the ground, it often makes sense for healthcare stakeholders to acquire them, salvage their best people and technologies and awaken them from a zombie-like existence,” said Kaveh Safavi, managing director for Accenture’s global healthcare business.

A three-pronged benefit

The benefits for vultures, in this sense, is three-fold. First, some genuine talent can be acquired and, considering the shortfall in this niche labour pool, that’s huge.